These stocks made my share portfolio a market-beater in 2024

Beating the market is the least important takeaway from this year.

Man in an office celebrates at he crosses a finish line before his colleagues.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Perhaps unexpectedly, 2024 has been a phenomenal year for anyone with a decently diversified share portfolio. The highest Australian interest rate in 13 years has proved insufficient to derail markets, which have kept chugging like a freight train.

Of course, the year isn't over, and anything can happen. But I'll risk prematurely counting my chickens to squeeze in my annual review before everyone is comatose from too much trifle and plum pudding… myself included.

Reflection is a grossly undervalued practice — not just for investing but also in life. After all, "Those who fail to learn from history are doomed to repeat it." By reviewing what has transpired before, we can better understand what should be done moving forward.

As of today, my stock-picking portfolio has returned 63.9% in 2024 (including dividends). How does that compare to the broader market? Below are a few indices to stack it up against:

  • S&P/ASX 200 Index (ASX: XJO) gross total return of 12.3%
  • S&P 500 Index (SP: .INX) return of 27.6%
  • Nasdaq Composite (NASDAQ: .IXIX) return of 35.0%
  • iShares MSCI World ETF (NYSE: URTH) return of 22.3%

I won't claim to be some Sage of the Sunshine State. Some years are better than others, and to claim victory as an investor because of one good year would be fallacious. But there is merit in deciphering what worked and trying to replicate the success repeatedly.

What's inside the share portfolio?

In many ways, this year has been a continuation of the last. Again, tech and consumer discretionary have shined bright despite crimped household budgets.

Some of this is arguably fuelled by the excitement surrounding artificial intelligence. This is supported by such companies seeing their valuations soar more from an increasing price-to-earnings (P/E) ratio than profit growth.

It makes the stellar year somewhat hard to celebrate. Yes, in the short term, it's great for the ego and the wealth on paper. However, it's not what you want as an investor in the long run. The premium paid for a slice in a company can not expand forever; eventually, its earning power must support it.

A few of my top holdings, Tesla and Apple, are guilty of this earnings-deficient rally. The heightened premium probably reflects optimism about future profitability as we hopefully emerge from a high interest rate environment.

CompanyYTD return% of Portfolio
Tesla Inc (NASDAQ: TSLA)75.6%21.9%
Palantir Technologies Inc (NASDAQ: PLTR)358.8%12.7%
Pro Medicus Limited (ASX: PME)159.5%11.9%
Resmed CDI (ASX: RMD)47.4%7.7%
Apple Inc (NASDAQ: AAPL)33.7%6.7%
Jumbo Interactive Ltd (ASX: JIN)-0.3%5.7%
Meta Platforms Inc (NASDAQ: META)79.1%5.6%
Aristocrat Leisure Limited (ASX: ALL)66.7%4.6%
Propel Funeral Partners Ltd (ASX: PFP)13.1%3.3%
Advanced Micro Devices Inc (NASDAQ: AMD)-8.4%2.8%
Alphabet Inc (NASDAQ: GOOG)37.1%2.7%
Lynas Rare Earths Ltd (ASX: LYC)-6.2%2.3%
Block Inc CDI (ASX: SQ2)28.4%2.3%
Macquarie Group Ltd (ASX: MQG)22.3%1.7%
Albemarle Corporation (NYSE: ALB)-32.3%1.3%
Commonwealth Bank of Australia (ASX: CBA)39.7%1.2%
Sonic Healthcare Ltd (ASX: SHL)-13.4%1.1%
Inmode Ltd (NASDAQ: INMD)-17.8%1.1%
Shriro Holdings Ltd (ASX: SHM)-7.4%1.1%
Lovisa Holdings Ltd (ASX: LOV)20.0%1.1%
Smartgroup Corporation Ltd (ASX: SIQ)-10.9%0.9%
Cash0.3%
Data as of 16 December 2024

A few notable changes were made to my share portfolio this year.

  • Increased my ResMed position
  • Increased my Meta position (the owner of Facebook, Instagram, and WhatsApp)
  • Added Aristocrat Leisure
  • Added Alphabet (the owner of Google)
  • Reduced my Propel Funeral Partners position on dilutionary concerns
  • Exited Duxton Water amid worsening execution
  • Exited Elders on increasing margin pressure

Ultimately, my big winners of 2024 are Tesla, Palantir, Pro Medicus, ResMed, Meta, and Aristocrat. In many cases, these are companies that have been (and possibly continue to be) misunderstood.

ResMed is a prime example. Investors ditched the sleep apnea maker, worried that weight-loss drugs would demolish its market. So far, the impact has failed to materialise, with some suggesting the Ozempic craze is giving the sleep apnea market a boost.

I think the lesson here is that it pays to build conviction. Once you've built a conviction based on logic, it's much harder to lose money through emotionally driven decisions.

Change afoot in 2025

A big part of investing is knowing thyself.

I have limited mining knowledge. So, what am I doing investing in Lynas and Albemarle?

Data as of 16 December 2024

Both investments were added to my share portfolio several years ago, rooted in basic supply and demand principles.

While I've managed to achieve decent returns from both, it isn't a great way to invest realistically. A business is more than its market, and I don't possess the comprehension to understand whether Lynas or Albemarle are good companies compared to their peers based on their resources.

For the above reason, I'll probably sell a few positions in 2025 and redeploy the money to companies I can better understand.

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Motley Fool contributor Mitchell Lawler has positions in Advanced Micro Devices, Albemarle, Alphabet, Apple, Aristocrat Leisure, Block, Commonwealth Bank Of Australia, InMode, Jumbo Interactive, Lovisa, Lynas Rare Earths Ltd, Macquarie Group, Meta Platforms, Palantir Technologies, Pro Medicus, Propel Funeral Partners, ResMed, Shriro, Smartgroup, Sonic Healthcare, and Tesla. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Advanced Micro Devices, Alphabet, Apple, Block, InMode, Jumbo Interactive, Lovisa, Macquarie Group, Meta Platforms, Palantir Technologies, ResMed, and Tesla. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, and Smartgroup. The Motley Fool Australia has recommended Advanced Micro Devices, Alphabet, Apple, Jumbo Interactive, Lovisa, Meta Platforms, Pro Medicus, and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Technology Shares

Life360 shares: A generational opportunity to get rich?

I think the Life360 share price could more than double again in the year ahead.

Read more »

A woman makes the task of vacuuming fun, leaping while she pretends it is an air guitar.
Opinions

Opinion: This is one of the best ASX growth shares to own for the next 5 years

This stock is rapidly growing, and I’m excited about it.

Read more »

Male and female workers at a steel factory.
Opinions

2 ASX 200 shares that could soar while Donald Trump is US President

These stocks may have a positive future.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Opinions

Prediction: These ASX 200 shares could be among 2025's big winners

These businesses have compelling tailwinds in 2025 and beyond.

Read more »

An older woman high fives an older man with big smiles after seeing good news on their laptop regarding their ASX tech shares
Opinions

If I were in my 50s I'd buy these compelling ASX stocks

I believe these options are appealing for people planning for retirement.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Opinions

Where will Wesfarmers shares be in 3 years?

Can this business keep impressing the market?

Read more »

A young man goes over his finances and investment portfolio at home.
Dividend Investing

2 ASX dividend stocks I'm thinking about buying in February

I’m considering these shares for passive income.

Read more »

Nervous customer in discussions at a bank.
Bank Shares

Is the ANZ share price a buy? Here's my view

Can investors bank on further gains from ANZ?

Read more »